Open AccessFollow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group
Author(s) -
Alexandra Peyser,
Nathaniel MacHardy,
Freya Tarapore,
Jacqueline MacHardy,
Leslie Powell,
Debbie S. Gipson,
Virginia J. Savin,
Cynthia X. Pan,
Theresa Kump,
Suzanne Vento,
Howard Trachtman
Publication year - 2010
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/jst0-fm48
Subject(s) - rosiglitazone , medicine , adalimumab , group (periodic table) , font , computer science , chemistry , artificial intelligence , receptor , organic chemistry , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom